• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Type 2 Diabetes Mellitus Treatment Market Size

    ID: MRFR/Pharma/4214-HCR
    85 Pages
    Rahul Gotadki
    September 2025

    Type 2 Diabetes Mellitus Treatment Market Research Report Information By Treatment (Drug (Insulin, Sensitizers, Sglt-2, Alpha-Glucosidase Inhibitors, Others), Devices (Blood Glucose Monitoring, Insulin Delivery Devices)), By The End User – Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Type 2 Diabetes Mellitus Treatment Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Type 2 Diabetes Mellitus Treatment Size

    Market Size Snapshot

    Year Value
    2024 USD 18.86 Billion
    2032 USD 39.18 Billion
    CAGR (2024-2032) 9.45 %

    Note – Market size depicts the revenue generated over the financial year

    The Type 2 diabetes treatment market is estimated to reach $39.18 billion by 2032. This represents a CAGR of 9.46% during the forecast period. The main reason for this increase is the increasing prevalence of Type 2 diabetes. This increase is primarily driven by the rise in obesity, sedentary lifestyles, and the aging population. The development of new drugs and digital health solutions are also driving market growth. The leading companies, such as Novo Nordisk, Sanofi, and Eli Lilly, are investing heavily in R&D to improve their products. Strategic initiatives are increasingly common, such as collaborations and partnerships aimed at integrating diabetes management and technology. Glucose monitoring systems and mobile health applications are changing the way diabetes is treated and patients adhere to their treatment regimens. These trends are expected to play a key role in shaping the future of the Type 2 diabetes treatment market.

    home-ubuntu-www-mrf_ne_design-batch-6-cp-type-2-diabetes-mellitus-treatment-market size

    Regional Market Size

    Regional Deep Dive

    The treatment of diabetes mellitus is undergoing considerable growth in all regions, owing to the increase in the prevalence of diabetes, the advancement of treatment and the heightened awareness of diabetes. North America, where there is a high uptake of new drugs and a strong health care system, is characterized by the rapid acceptance of new drugs and the strong regulatory environment. Europe is characterized by a high level of prevention and stricter regulations. The Asia-Pacific region is experiencing rapid growth due to the increase in urbanization and lifestyle changes, while the Middle East and Africa are faced with special challenges due to the low level of access to health care and the disparity in economic development. Latin America is also a major player in the field of diabetes mellitus, with increasing investments in health care and a growing middle class with an increased health consciousness.

    Europe

    • The European Medicines Agency (EMA) has introduced streamlined approval processes for diabetes medications, encouraging innovation and faster access to new treatments for patients.
    • Countries like Germany and the UK are implementing national diabetes prevention programs that focus on lifestyle interventions, which are expected to reduce the incidence of Type 2 diabetes and subsequently impact treatment demand.

    Asia Pacific

    • China is witnessing a surge in Type 2 diabetes cases, prompting the government to launch initiatives aimed at increasing public awareness and improving access to diabetes care and treatment.
    • Innovative digital health solutions, such as mobile apps for diabetes management, are gaining popularity in countries like India and Australia, enhancing patient engagement and adherence to treatment regimens.

    Latin America

    • Brazil has launched a national diabetes control program that aims to improve screening and treatment access, which is expected to significantly impact the management of Type 2 diabetes in the region.
    • Pharmaceutical companies are increasingly investing in local production facilities in Latin America, which is anticipated to lower drug prices and improve availability of diabetes treatments.

    North America

    • The U.S. Food and Drug Administration (FDA) has recently approved several new medications for Type 2 diabetes, including novel GLP-1 receptor agonists, which are expected to enhance treatment options and improve patient outcomes.
    • Telehealth services have gained traction in the U.S. and Canada, allowing for better management of diabetes through remote monitoring and consultations, which is particularly beneficial for patients in rural areas.

    Middle East And Africa

    • The World Health Organization (WHO) has initiated programs in several African countries to improve diabetes care, focusing on education and access to essential medications.
    • In the Gulf Cooperation Council (GCC) countries, there is a growing emphasis on lifestyle modification programs, supported by local governments, to combat the rising prevalence of Type 2 diabetes.

    Did You Know?

    “Approximately 90-95% of all diabetes cases are Type 2, and the condition is often preventable through lifestyle changes such as diet and exercise.” — Centers for Disease Control and Prevention (CDC)

    Segmental Market Size

    The Type 2 diabetes treatment market is characterized by the growing segment of new therapeutic solutions, including oral medicines, injections, and lifestyle management. This segment is growing due to the growing prevalence of diabetes, increasing awareness of the disease, and the development of treatment solutions. The growing prevalence of obesity, which is closely related to Type 2 diabetes, and the growing demand for individualized treatment are the main drivers. The exploitation phase of this segment is currently in a period of maturity, with companies such as Novo Nordisk and Eli Lilly leading in the development of new medicines and the introduction of patient management solutions. The most important new medicines are the GLP-1 agonists and the SGLT2 blockers, which have become well established in the clinical environment. The main patient management solutions are medication adherence, telemedicine, and integrated diabetes management. The growth of the market is also driven by a greater focus on prevention and by government initiatives to increase diabetes awareness. The technological development of the segment is influenced by the development of continuous blood sugar monitoring systems and mobile health applications, which increase the patient's involvement in treatment and improve treatment outcomes.

    Future Outlook

    The type 2 diabetes treatment market is set to grow at a CAGR of 9.46% from 2024 to 2032. This growth will be driven by the rising prevalence of type 2 diabetes, a result of increasing obesity rates, sedentary lifestyles, and an aging population. The market will be characterized by a high penetration of diabetes treatments. Compared to 2024, penetration is expected to increase from around 30% to around 50% by 2032. This will be attributed to a higher acceptance of pharmacological and non-pharmacological interventions among patients and health care professionals. In addition, several technological developments, such as the development of novel oral medications, continuous glucose monitoring systems, and digital health solutions, will reshape the treatment landscape. And supportive policy frameworks, which aim to improve access to and affordability of diabetes care, will also boost growth. The integration of artificial intelligence into diabetes treatment regimens and the development of individualized therapies are expected to improve patient outcomes and adherence to treatment. Against this backdrop, companies will have to stay agile to capitalize on these trends and meet the rising demand for effective and novel diabetes treatments.

    Type 2 Diabetes Mellitus Treatment Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Type 2 Diabetes Mellitus Treatment Market was valued at USD 18.53 Billion in 2023 and is projected to grow to USD 39.18 Billion by 2032, with a CAGR of 9.45% from 2024 to 2032. The market is driven by rising technological advancements, increasing prevalence of diabetes, and growing awareness about the condition. Key players are developing novel drugs and devices, such as Ozempic and Steglatro, to address the unmet medical needs. However, challenges such as high treatment costs and side effects may hinder growth. The Americas dominate the market due to high healthcare expenditure and patient population, while Asia Pacific is the fastest-growing region.

    Key Market Trends & Highlights

    The Type 2 Diabetes Mellitus Treatment Market is witnessing significant growth driven by various factors.

    • Market Size in 2023: USD 18.53 Billion
    • Projected Market Size by 2032: USD 39.18 Billion
    • CAGR from 2024 to 2032: 9.45%
    • 9.4% of the U.S. population had diabetes in 2015, equating to 30.3 million people

    Market Size & Forecast

    2023 Market Size USD 18.53 Billion
    2024 Market Size USD 18.86 Billion
    2032 Market Size USD 39.18 Billion
    CAGR (2024-2032) 9.45%

    Major Players

    Abbott Laboratories, Acon Laboratories, Inc., Adocia, Akros Pharma, Amgen, AstraZeneca, Bayer AG, Becton Dickinson and Company, Biocon, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Merck, Novartis & Co., Novo Nordisk, Peptron, Pfizer, Roche Diagnostics Ltd., Sanofi, Sunpharma, Takeda Pharmaceuticals

    Market Trends

    The increasing prevalence of Type 2 Diabetes Mellitus is driving a paradigm shift towards more personalized treatment approaches, emphasizing the need for innovative therapies and comprehensive management strategies.

    Centers for Disease Control and Prevention (CDC)

    Type 2 Diabetes Mellitus Treatment Market Market Drivers

    Rising Prevalence of Type 2 Diabetes

    The increasing prevalence of Type 2 Diabetes Mellitus globally is a primary driver for the Global Type 2 Diabetes Mellitus Treatment Market Industry. As lifestyle changes and dietary habits contribute to higher obesity rates, the World Health Organization indicates that the number of adults with diabetes has risen significantly. In 2024, the market is projected to reach 18.9 USD Billion, reflecting the urgent need for effective treatment options. This trend is expected to continue, with estimates suggesting that by 2035, the market could expand to 51.4 USD Billion, highlighting the growing demand for innovative therapies and management solutions.

    Market Segment Insights

    Regional Insights

    Key Companies in the Type 2 Diabetes Mellitus Treatment Market market include

    Industry Developments

    • Q2 2025: ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide At the 85th Scientific Sessions of the American Diabetes Association in June 2025, Eli Lilly's tirzepatide (Mounjaro, Zepbound) was highlighted for its unique mechanism and clinical data supporting its use in type 2 diabetes management. The session provided updated insights into tirzepatide’s FDA-approved indications and its role in personalized treatment plans.

    Type 2 Diabetes Mellitus Treatment Market Regional Analysis

    The Americas dominate the type 2 diabetes mellitus treatment market owing to the presence of patient population, a well-developed technology, high healthcare expenditure, and the presence of the leading players. Due to the rising prevalence of diabetes, various companies, and government associations are actively participating in improving diabetes care. For instance, The Merck Foundation has provided funding of around USD 10,000,000 for the projects designed to improve diabetes care in the United States.

    Europe holds the second position in the type 2 diabetes mellitus treatment market. It is expected that the government support towards research & development expenditure and amendments in reimbursement policies in the healthcare is likely to drive the European market. As per the German maternity guidelines, every pregnant woman can undergo glucose challenge test for the early diagnosis of Gestational diabetes mellitus, and the charges for the test are completely covered by women’s health insurance.

    Asia Pacific is the fastest growing type 2 diabetes mellitus treatment market owing to a huge patient pool, increasing demand, and development in healthcare technology.

    The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

    Type 2 Diabetes Mellitus Treatment Market Key Players

    Some of key the players in the global type 2 diabetes mellitus treatment market are: 

    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • Adocia
    • Akros Pharma
    • Amgen
    • AstraZeneca
    • Bayer AG
    • Becton 
    • Dickinson and Company
    • Biocon
    • Boehringer Ingelheim
    • Daiichi Sankyo
    • Eli Lilly
    • Merck
    • Novartis & Co.
    • Novo Nordisk
    • Peptron
    • Pfizer
    • Roche Diagnostics Ltd.
    • Sanofi
    • Sunpharma
    • Takeda Pharmaceuticals

    Intended Audience

    • Pharmaceutical Companies
    • Medical Device Companies
    • Research and Development (R&D) Companies
    • Diagnostic Laboratories
    • Government Research Institute
    • Academic Institutes and Universities

    Future Outlook

    Type 2 Diabetes Mellitus Treatment Market Future Outlook

    The Type 2 Diabetes Mellitus Treatment Market is projected to grow at a 9.54% CAGR from 2024 to 2032, driven by increasing prevalence, technological advancements, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop personalized medicine approaches to enhance treatment efficacy and patient adherence.
    • Invest in digital health solutions for remote monitoring and management of diabetes.
    • Expand access to affordable treatment options in emerging markets to capture new patient demographics.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment and increased global awareness.

    Market Segmentation

    Type 2 Diabetes Mellitus Treatment Market Segmentation

    Intended Audience
    • Pharmaceutical Companies
    • Medical Device Companies
    • Research and Development (R&D) Companies
    • Diagnostic Laboratories
    • Government Research Institute
    • Academic Institutes and Universities

    Report Scope

    Report Attribute/Metric Details  
      Market Size   USD 39.18 Billion by 2032  
      CAGR   9.45%  
      Base Year 2023  
      Forecast Period   2024-2032  
      Historical Data Market Size 2023 18.53 (USD Billion)
      Forecast Units Market Size 2024 18.86 (USD Billion)
      Report Coverage Market Size 2032 39.18 (USD Billion)
      Segments Covered Compound Annual Growth Rate (CAGR) 9.45 % (2024 - 2032)
      Geographies Covered Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Key Vendors Base Year 2023
      Key Market Opportunities Market Forecast Period 2024 - 2032
      Key Market Drivers Historical Data 2018-2022

     

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table of Contents
    2. Chapter 1.    Report Prologue  
    3.  
    4. Chapter 2.    Market Introduction    
      1.     Definition    
      2.     Scope
    5. of the Study    
      1.     Research Objective  
        1.     Assumptions    
        2.   
    6.  Limitations    
    7. Chapter 3.    Research
    8. Methodology
      1.     Introduction
      2.     Primary
    9. Research    
      1.     Secondary research  
      2.     Market Size Estimation
    10. Chapter 4.  
    11.  Market Dynamics
      1.     Drivers    
      2.   
    12.  Restrains
      1.     Opportunities    
      2.   
    13.  Challenges
      1.     Macroeconomic Indicators
      2.   
    14.  Technology Trends & Assessment          
    15. Chapter 5.    Market Factor Analysis
      1.   
    16.  Porter’s Five Forces Analysis
      1.     Bargaining
    17. Power of Suppliers    
      1.     Bargaining Power
    18. of Buyers
      1.     Threat of New Entrants    
        1.     Threat of Substitutes    
        2.   
    19.  Intensity of Rivalry    
      1.     Value Chain
    20. Analysis
      1.     Investment Feasibility Analysis  
      2.     Pricing Analysis
    21. Chapter 6.    Global
    22. Type 2 diabetes mellitus treatment Market, by treatment
      1.     Introduction
      2.     Drug Class
        1.     Market Estimates
    23. & Forecast, 2020 – 2027
      1.     Devices
        1.   
    24.  Market Estimates & Forecast, 2020 – 2027
      1.     Others
        1.     Market Estimates & Forecast, 2020 – 2027
    25. Chapter 7.    Global Type 2 diabetes mellitus treatment Market,
    26. by End User
      1.     Introduction
      2.     Hospitals 
        1.     Market Estimates & Forecast, 2020 – 2027
      3.     Clinics
        1.     Market Estimates &
    27. Forecast, 2020 – 2027
      1.     Diagnostic Centers
        1.   
      2.     Drug
    28. Stores
      1.     Market Estimates & Forecast, 2020 –
    29. 2027
      1.     Pharmacies
        1.     Market Estimates
      2.     Others
        1.   
    30. Chapter 8.  
    31.  Global Type 2 diabetes mellitus treatment Market, by Region
      1.   
    32.  Introduction
      1.     Americas
        1.     North
    33. America
      1.     U.S.
        1.     Canada
        2.     South America
      2.     Europe
        1.   
    34.  Western Europe
      1.     Germany
        1.   
    35.  France
      1.     Italy
        1.     Spain
        2.     Eastern Europe
      2.     Asia Pacific
        1.     Japan
        2.     China
        3.   
    36.  India
      1.     Australia
        1.     Republic
    37. of Korea
      1.     Rest of Asia Pacific
      2.   
    38.  The Middle East & Africa
      1.     United Arab Emirates
        1.      Saudi Arabia
        2.     Oman
        3.   
    39.  Kuwait
      1.     Qatar
        1.     Rest
    40. of the Middle East & Africa
    41. Chapter 9    Company Landscape  
      1.     Introduction    
      2.   
    42.  Market Share Analysis    
      1.     Key Development
    43. & Strategies    
      1.     Key Developments  
    44. Chapter 10    Company Profiles    
      1.     Abbott Laboratories 
        1.     Company
    45. Overview    
      1.     Types Overview  
        1.     Financials    
        2.   
    46.  SWOT Analysis    
      1.     AstraZeneca  
        1.     Company Overview    
        2.   
    47.  Types Overview    
      1.     Financial
        1.     Key Developments  
        2.     SWOT Analysis    
      2.   
    48.  Eli Lilly
      1.     Company Overview    
        1.     Types Overview    
        2.   
    49.  Financial Overview
      1.     Key Development  
        1.     SWOT Analysis    
      2.   
    50.  Merck
      1.     Company Overview    
        1.     Types/Business Segment Overview    
        2.     Financial Overview    
        3.   
    51.  Key Development    
      1.     SWOT Analysis  
      2.     BECTON, DICKINSON AND COMPANY
        1.   
    52.  Company Overview    
      1.     Types Overview  
        1.     Financial overview    
        2.   
    53.  Key Developments    
      1.     Sanofi  
        1.     Company Overview    
        2.   
        3.     Financial
        4.     Key Developments  
      2.     BOEHRINGER INGELHEIM
        1.   
    54.  Overview    
      1.     Types Overview  
        1.     Financials    
        2.   
        3.     SWOT Analysis  
    55.         10.8    Others
    56. Chapter 11    MRFR Conclusion    
      1.   
    57.  Key Findings    
      1.     From CEO’s
    58. View Point    
      1.     Unmet Needs of the Market  
      2.     Key Companies to Watch    
      3.     Prediction of Type 2 diabetes mellitus treatment industry
    59. Chapter 12    Appendix
    60. LIST OF TABLES
    61. Table
    62. 1        Type 2 diabetes mellitus treatment Industry
    63. Synopsis, 2020 – 2027
    64. Table 2        Type
    65. diabetes mellitus treatment Market Estimates and Forecast, 2020 – 2027,
    66. (USD Million)
    67. Table 3        Type 2 diabetes
    68. mellitus treatment Market by Region, 2020 – 2027, (USD Million)
    69. 4        Type 2 diabetes mellitus treatment Market
    70. by Treatment, 2020 – 2027, (USD Million)
    71. Table 5      
    72.  Type 2 diabetes mellitus treatment Market by End Users, 2020 – 2027,
    73. Table 6     North America Type 2 diabetes mellitus
    74. treatment Market by Treatment, 2020 – 2027, (USD Million)
    75. Table 7   
    76.  North America Type 2 diabetes mellitus treatment Market by End Users, 2020
    77. – 2027, (USD Million)
    78. Table 8     US Type 2 diabetes mellitus
    79. Table 9   
    80.  US Type 2 diabetes mellitus treatment Market by End Users, 2020 – 2027,
    81. Table 10    Canada Type 2 diabetes mellitus treatment
    82. Market by Treatment, 2020 – 2027, (USD Million)
    83. Table 11  
    84.  Canada Type 2 diabetes mellitus treatment market by End Users, 2020 –
    85. 2027, (USD Million)
    86. Table 12    South America Type 2 diabetes
    87. mellitus treatment Market by Treatment, 2020 – 2027, (USD Million)
    88. 13    South America Type 2 diabetes mellitus treatment Market by
    89. End Users, 2020 – 2027, (USD Million)
    90. Table 14    Europe
    91. Type 2 diabetes mellitus treatment Market by Treatment, 2020 – 2027, (USD
    92. Million)
    93. Table 15    Europe Type 2 diabetes mellitus treatment
    94. Market by End Users, 2020 – 2027, (USD Million)
    95. Table 16  
    96.  Western Europe Type 2 diabetes mellitus treatment Market by Treatment, 2020
    97. Table 17    Western Europe Type
    98. diabetes mellitus treatment Market by End Users, 2020 – 2027, (USD Million)
    99. Table 18    Eastern Europe Type 2 diabetes mellitus treatment Market
    100. Table 19    Eastern
    101. Europe Type 2 diabetes mellitus treatment Market by End Users, 2020 – 2027,
    102. Table 20    Asia Pacific Type 2 diabetes mellitus
    103. Table 21  
    104.  Asia Pacific Type 2 diabetes mellitus treatment market by End Users, 2020
    105. Table 22    The Middle East &
    106. Africa Type 2 diabetes mellitus treatment Market by Treatment, 2020 – 2027,
    107. Table 23    The Middle East & Africa Type
    108. LIST OF FIGURES
    109. Figure 1    Research Process
    110. Figure 2    Segmentation for Type 2 diabetes mellitus treatment
    111. Market
    112. Figure 3    Segmentation Market Dynamics for Type 2 diabetes
    113. mellitus treatment Market
    114. Figure 4    Global Type 2 diabetes
    115. mellitus treatment market Share, by Treatment 2020
    116. Figure 5    Global
    117. Type 2 diabetes mellitus treatment market Share, by End Users, 2020
    118. Figure
    119. 6    Global Type 2 diabetes mellitus treatment market Share, by Region,
    120. 2020
    121. Figure 7    North America Type 2 diabetes mellitus treatment
    122. market Share, by Country, 2020
    123. Figure 8    Europe Type 2 diabetes
    124. mellitus treatment market Share, by Country, 2020
    125. Figure 9    Asia
    126. Pacific Type 2 diabetes mellitus treatment market Share, by Country, 2020
    127. 10    Middle East & Africa Type 2 diabetes mellitus treatment
    128. Figure 11    Global Type 2 diabetes
    129. mellitus treatment market: Company Share Analysis, 2020 (%)
    130. Figure 12  
    131.  Abbott Laboratories: Key Financials
    132. Figure 13    Abbott
    133. Laboratories: Segmental Revenue
    134. Figure 14    Abbott Laboratories:
    135. Geographical Revenue
    136. Figure 15    AstraZeneca: Key Financials
    137. Figure 16    AstraZeneca: Segmental Revenue
    138. Figure 17  
    139.  AstraZeneca: Geographical Revenue
    140. Figure 18    Eli Lilly:
    141. Key Financials
    142. Figure 19    Eli Lilly: Segmental Revenue
    143. Figure 20    Eli Lilly: Geographical Revenue
    144. Figure 21  
    145.  Merck: Key Financials
    146. Figure 22    Merck: Segmental Revenue
    147. Figure 23    Merck: Geographical Revenue
    148. Figure 24  
    149.  BECTON, DICKINSON AND COMPANY: Key Financials
    150. Figure 25    BECTON,
    151. DICKINSON AND COMPANY: Segmental Revenue
    152. Figure 26    BECTON,
    153. DICKINSON AND COMPANY Geographical Revenue
    154. Figure 27    Sanofi:
    155. Figure 28    Sanofi: Segmental Revenue
    156. 29    Sanofi: Geographical Revenue
    157. Figure 30    BOEHRINGER
    158. INGELHEIM: Key Financials
    159. Figure 31    BOEHRINGER INGELHEIM:
    160. Segmental Revenue
    161. Figure 32    BOEHRINGER INGELHEIM: Geographical
    162. Revenue

    Type 2 Diabetes Mellitus Treatment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials